The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cheng Sohanya Roshan since 2022.
This trader's CIK number is 1865796.
At the time of last reporting, Cheng Sohanya Roshan was the EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc.. (stock ticker symbol KPTI).
Also see all insider trading activities at Karyopharm Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | KPTI | 0 | $0 | 3,445 | $21,669 | 0 | $0 |
2024 | KPTI | 0 | $0 | 32,305 | $35,549 | 0 | $0 |
2023 | KPTI | 0 | $0 | 18,654 | $43,911 | 0 | $0 |
2022 | KPTI | 0 | $0 | 1,551 | $8,178 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-04 | KPTI | Sale | 3,445 | 6.29 | 21,669 |
2024-09-04 | KPTI | Sale | 5,356 | .72 | 3,867 |
2024-02-29 | KPTI | Sale | 21,840 | 1.17 | 25,552 |
2024-03-01 | KPTI | Sale | 5,109 | 1.20 | 6,130 |
2023-09-01 | KPTI | Sale | 7,415 | 1.33 | 9,869 |
2023-03-01 | KPTI | Sale | 11,239 | 3.03 | 34,042 |
2022-06-13 | KPTI | Sale | 1,551 | 5.27 | 8,178 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cheng Sohanya Roshan (EVP & Chief Commercial Officer of Karyopharm Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.